Pfizer COVID-19 vaccine highly effective in adolescents

Twelve- to 15-year-olds had a powerful immune response with Pfizer vaccine.

There were no serious side effects. The Pfizer / BioNTech COVID-19 vaccine is highly effective in 12- to 15-year-olds, none of the children who received strong.

There were no serious UFABET side effects. The study included 2,260 participants. Around half received the two-dose vaccine. Based on the study, the vaccine was 100 percent effective in this age group. The study was small, though, so it’s difficult to say if that number will hold up in a larger group. 

Pfizer COVID-19 vaccine highly effective in adolescents

The study was small, though, so it’s difficult to say if that number will hold up in a larger group. 

The 12- to 15-year-olds also had higher levels of antibodies one month after the second dose of the vaccine than people between 16 and 25 years old, the company said.

Right now, the Pfizer / BioNTech vaccine is authorized for people 16 years of age and older. The companies said they plan to ask the Food and Drug Administration to expand the authorization and allow the shots to be used for 12- to 15-year-olds as well.

Albert Bourla, chief executive officer of Pfizer, said in a press release that the company hopes this age group can be vaccinated before the next school year.

Although children rarely get seriously ill from the disease, they can still get sick and sometimes develop long-lasting symptoms. They can also contract and spread the virus.

That vaccine is currently authorized for people 18 and older. Johnson & Johnson, which also has a vaccine authorized for people 18 and older